Literature DB >> 5464477

The second component of human complement (C2): quantitative molecular analysis of its reactions in immune hemolysis.

N R Cooper, M J Polley, H J Müller-Eberhard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5464477     DOI: 10.1016/0019-2791(70)90237-5

Source DB:  PubMed          Journal:  Immunochemistry        ISSN: 0019-2791


× No keyword cloud information.
  23 in total

1.  Complement bridges between cells analysis of a possible cell-cell interaction mechanism.

Authors:  M P Dierich; B Landen
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

2.  Initiation of the alternative pathway of complement: recognition of activators by bound C3b and assembly of the entire pathway from six isolated proteins.

Authors:  R D Schreiber; M K Pangburn; P H Lesavre; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

3.  Complement subcomponent C1q secreted by cultured human monocytes has subunit structure identical with that of serum C1q.

Authors:  A J Tenner; D B Volkin
Journal:  Biochem J       Date:  1986-01-15       Impact factor: 3.857

4.  Formation and biologic role of polyoma virus-antibody complexes. A critical role for complement.

Authors:  M B Oldstone; N R Cooper; D L Larson
Journal:  J Exp Med       Date:  1974-08-01       Impact factor: 14.307

5.  Cell cycle-dependent immune lysis of Moloney virus-transformed lymphocytes: presence of viral antigen, accessibility to antibody, and complement activation.

Authors:  R A Lerner; M B Oldstone; N R Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  1971-10       Impact factor: 11.205

6.  Activation of the alternative and classical complement pathways by Entamoeba histolytica.

Authors:  J Calderon; R D Schreiber
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

7.  Activation of the alternative complement pathway in systemic lupus erythematosus.

Authors:  M R Wilson; C M Arroyave; R M Nakamura; J H Vaughan; E M Tan
Journal:  Clin Exp Immunol       Date:  1976-10       Impact factor: 4.330

8.  Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complement.

Authors:  G R Nemerow; F C Jensen; N R Cooper
Journal:  J Clin Invest       Date:  1982-11       Impact factor: 14.808

9.  The effects of iodine and thiol-blocking reagents on complement component C2 and on the assembly of the classical-pathway C3 convertase.

Authors:  M A Kerr; C Parkes
Journal:  Biochem J       Date:  1984-04-15       Impact factor: 3.857

10.  Pathogenetic mechanisms in dengue haemorrhagic fever: report of an international collaborative study.

Authors: 
Journal:  Bull World Health Organ       Date:  1973       Impact factor: 9.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.